 |
|
Outpatient Use of Prescription Sedative-Hypnotic Drugs in the United States, 1970 Through 1989
Diane K. Wysowski, PhD;
Carlene Baum, PhD
Arch Intern Med. 1991;151(9):1779-1783.
Abstract
| |
Data from two pharmaceutical marketing research data bases, the National Prescription Audit and the National Disease and Therapeutic Index, were used to study outpa tient use of prescription sedative-hypnotic drugs in the United States from 1970 through 1989. Retail pharmacies dispensed an estimated 62.5 million prescriptions for sedative-hypnotic drugs in 1970. This number declined by half to 31.6 million in 1978. This decline has continued, so that in 1989 there were 20.8 million dispensed prescrip tions. From 1970 to 1989, barbiturate and nonbarbiturate nonbenzodiazepine prescriptions decreased 24-fold and 18-fold, respectively, and benzodiazepine prescriptions in creased 26-fold. By 1989, the ultrashort-acting benzodiaz epine drug triazolam was the leading sedative hypnotic, with about 40% of the total sedative-hypnotic market in the 6 years since its marketing. Data also indicate shifts from longer to shorter acting, and from higher to lower dose, benzodiazepine prescriptions, increasing use of antidepres sant drugs for insomnia, female predominance of use, and increasing use with age.
(Arch Intern Med. 1991;151:1779-1783)
Author Affiliations
From the Division of Epidemiology and Surveillance, Office of Epidemiology and Biostatistics, Food and Drug Administration, Rockville, Md.
Footnotes
Accepted for publication February 11, 1991.
This article contains the views of the authors and not necessarily those of the Food and Drug Administration.
Reprints not available.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Rapid Increase in the Use of Oral Antidiabetic Drugs in the United States, 1990-2001
Wysowski et al.
Diabetes Care 2003;26:1852-1855.
ABSTRACT
| FULL TEXT
Acute performance-impairing and subject-rated effects of triazolam and temazepam, alone and in combination with ethanol, in humans
Simpson and Rush
J Psychopharmacol 2002;16:23-34.
ABSTRACT
Medications as Social Phenomena
Cohen et al.
Health (London) 2001;5:441-469.
ABSTRACT
Meta-analysis of benzodiazepine use in the treatment of insomnia
Holbrook et al.
CMAJ 2000;162:225-233.
ABSTRACT
| FULL TEXT
Use of Benzodiazepines in the Community
Olfson and Pincus
Arch Intern Med 1994;154:1235-1240.
ABSTRACT
Management of Insomnia in Office-Based Practice: National Prevalence and Therapeutic Patterns
Radecki and Brunton
Arch Fam Med 1993;2:1129-1134.
ABSTRACT
|
